315 related articles for article (PubMed ID: 37146581)
41. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):3-17. PubMed ID: 30286296
[TBL] [Abstract][Full Text] [Related]
42. [Kidney organoids].
Steichen C; Giraud S; Hauet T
Med Sci (Paris); 2019 May; 35(5):470-477. PubMed ID: 31115331
[TBL] [Abstract][Full Text] [Related]
43. Dynamic 3D Combinatorial Generation of hPSC-Derived Neuromesodermal Organoids With Diverse Regional and Cellular Identities.
Whye D; Wood D; Kim KH; Chen C; Makhortova N; Sahin M; Buttermore ED
Curr Protoc; 2022 Oct; 2(10):e568. PubMed ID: 36264199
[TBL] [Abstract][Full Text] [Related]
44. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.
Freedman BS; Brooks CR; Lam AQ; Fu H; Morizane R; Agrawal V; Saad AF; Li MK; Hughes MR; Werff RV; Peters DT; Lu J; Baccei A; Siedlecki AM; Valerius MT; Musunuru K; McNagny KM; Steinman TI; Zhou J; Lerou PH; Bonventre JV
Nat Commun; 2015 Oct; 6():8715. PubMed ID: 26493500
[TBL] [Abstract][Full Text] [Related]
45. Pluripotent Stem Cell Platforms for Drug Discovery.
Chen KG; Mallon BS; Park K; Robey PG; McKay RDG; Gottesman MM; Zheng W
Trends Mol Med; 2018 Sep; 24(9):805-820. PubMed ID: 30006147
[TBL] [Abstract][Full Text] [Related]
46. Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids.
Kim JW; Nam SA; Yi J; Kim JY; Lee JY; Park SY; Sen T; Choi YM; Lee JY; Kim HL; Kim HW; Park J; Cho DW; Kim YK
Adv Sci (Weinh); 2022 May; 9(15):e2103526. PubMed ID: 35322595
[TBL] [Abstract][Full Text] [Related]
47. Modeling human liver organ development and diseases with pluripotent stem cell-derived organoids.
Ouchi R; Koike H
Front Cell Dev Biol; 2023; 11():1133534. PubMed ID: 36875751
[TBL] [Abstract][Full Text] [Related]
48. Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids.
Oishi H; Tabibzadeh N; Morizane R
Biofabrication; 2024 Apr; 16(3):. PubMed ID: 38547531
[TBL] [Abstract][Full Text] [Related]
49. Developing precision medicine using scarless genome editing of human pluripotent stem cells.
Steyer B; Cory E; Saha K
Drug Discov Today Technol; 2018 Aug; 28():3-12. PubMed ID: 30205878
[TBL] [Abstract][Full Text] [Related]
50. Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network.
Low JH; Li P; Chew EGY; Zhou B; Suzuki K; Zhang T; Lian MM; Liu M; Aizawa E; Rodriguez Esteban C; Yong KSM; Chen Q; Campistol JM; Fang M; Khor CC; Foo JN; Izpisua Belmonte JC; Xia Y
Cell Stem Cell; 2019 Sep; 25(3):373-387.e9. PubMed ID: 31303547
[TBL] [Abstract][Full Text] [Related]
51. Pluripotent stem cell derived intestinal organoids with an enteric nervous system.
Loffet E; Brossard L; Mahe MM
Methods Cell Biol; 2020; 159():175-199. PubMed ID: 32586442
[TBL] [Abstract][Full Text] [Related]
52. Modeling Human Gonad Development in Organoids.
Pryzhkova MV; Boers R; Jordan PW
Tissue Eng Regen Med; 2022 Dec; 19(6):1185-1206. PubMed ID: 36350469
[TBL] [Abstract][Full Text] [Related]
53. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.
Dick E; Rajamohan D; Ronksley J; Denning C
Biochem Soc Trans; 2010 Aug; 38(4):1037-45. PubMed ID: 20659000
[TBL] [Abstract][Full Text] [Related]
54. Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers.
Nguyen R; Bae SDW; Zhou G; Read SA; Ahlenstiel G; George J; Qiao L
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188350. PubMed ID: 32007597
[TBL] [Abstract][Full Text] [Related]
55. Human organoids in basic research and clinical applications.
Tang XY; Wu S; Wang D; Chu C; Hong Y; Tao M; Hu H; Xu M; Guo X; Liu Y
Signal Transduct Target Ther; 2022 May; 7(1):168. PubMed ID: 35610212
[TBL] [Abstract][Full Text] [Related]
56. Human Pluripotent Stem Cell-Derived Alveolar Organoid with Macrophages.
Seo HR; Han HJ; Lee Y; Noh YW; Cho SJ; Kim JH
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012471
[TBL] [Abstract][Full Text] [Related]
57. Human pluripotent stem cell-derived brain organoids as in vitro models for studying neural disorders and cancer.
Luo J; Li P
Cell Biosci; 2021 May; 11(1):99. PubMed ID: 34049587
[TBL] [Abstract][Full Text] [Related]
58. Human Pluripotent Stem Cells for High-Throughput Drug Screening and Characterization of Small Molecules.
Ryu S; Chu PH; Malley C; Braisted J; Ormanoglu P; Huang R; Itkin M; Itkin Z; Shinn P; Klumpp-Thomas C; Michael S; Tristan CA; Simeonov A; Singeç I
Methods Mol Biol; 2022; 2454():811-827. PubMed ID: 34128205
[TBL] [Abstract][Full Text] [Related]
59. Differentiation of Retinal Organoids from Human Pluripotent Stem Cells.
Chichagova V; Dorgau B; Felemban M; Georgiou M; Armstrong L; Lako M
Curr Protoc Stem Cell Biol; 2019 Sep; 50(1):e95. PubMed ID: 31479596
[TBL] [Abstract][Full Text] [Related]
60. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
